SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000925
Filing Date
2021-08-05
Accepted
2021-08-05 16:04:23
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-20210630.htm   iXBRL 10-Q 1959928
2 EX-10.2 aldx-20210630ex10_2.htm EX-10.2 74279
3 EX-31.1 aldx-20210630ex31_1.htm EX-31.1 15270
4 EX-31.2 aldx-20210630ex31_2.htm EX-31.2 15496
5 EX-32.1 aldx-20210630ex32_1.htm EX-32.1 13031
  Complete submission text file 0000950170-21-000925.txt   6335823

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aldx-20210630_pre.xml EX-101.PRE 252345
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aldx-20210630_cal.xml EX-101.CAL 39387
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aldx-20210630.xsd EX-101.SCH 43603
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aldx-20210630_def.xml EX-101.DEF 131372
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aldx-20210630_lab.xml EX-101.LAB 343929
11 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20210630_htm.xml XML 965682
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 211148098
SIC: 2834 Pharmaceutical Preparations